OBX Obsidian Therapeutics, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026OBX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
OBX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q2 2026 |
|---|---|---|
| Net Income | $0 |
Balance Sheet
| Metric | Trend | Q2 2026 |
|---|---|---|
| Current Assets | $0 | |
| Other Non-current Assets | $0 | |
| Total Assets | $0 | |
| Current Liabilities | $0 | |
| Other Non-current Liabilities | $0 | |
| Common Stock | $0 | |
| Retained Earnings | $0 | |
| AOCI | $0 | |
| Stockholders' Equity | $0 | |
| Liabilities + Equity | $0 | |
| Shares Outstanding | 1,000 |
Cash Flow
| Metric | Trend | Q2 2026 |
|---|---|---|
| Operating Cash Flow | $0 | |
| Investing Cash Flow | $0 | |
| Financing Cash Flow | $0 | |
| Net Change in Cash | $0 |
Per Share
| Metric | Trend | Q2 2026 |
|---|---|---|
| Book Value / Share | $0.00 |
Most recent period on the left · null values shown as ·
Company insiders 5 insiders · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Madan Jagasia | · | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| Matthew Norkunas | · | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| Robert W. Ross | · | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| Heidi Hagen | · | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| Maria Fardis | · | Aug. 3, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VRIG · Invesco Actively Managed Exchange-T… | 1.58% | 29,235,583.42 | Oct. 2, 2026 | Daily |
| GTO · Invesco Actively Managed Exchange-T… | 0.29% | 9,551,425.92 | Oct. 2, 2026 | Daily |
| GSY · Invesco Actively Managed Exchange-T… | 0.24% | 9,423,157.92 | Oct. 2, 2026 | Daily |
| GTOS · Invesco Actively Managed Exchange-T… | 0.20% | 238,449.34 | Oct. 2, 2026 | Daily |
OBX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
3 analysts · 2026-09-29Mean target $39.00 +187.0%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| OBX | · | · | · | · | · | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.